Skip to content
OpenCapital
Get started

MiMedx Group MDXG Cash & Equivalents

Cash & Equivalents at other companies

IAR
Integra LifeSciencesIART
$236.81M-1.0%
Artivion logo
ArtivionAORT
$55.76M+47.9%
Solventum logo
SolventumSOLV
$561M+5.1%
Vericel logo
VericelVCEL
$109.3M+37.1%
Enovis logo
EnovisENOV
$33.13M-13.9%
Tactile Systems Technology logo
Tactile Systems TechnologyTCMD
$74.99M-10.3%

Other financials

Income statement

See full
Revenue$59.0M-33.1%
Gross profit$41.6M-41.9%
Operating income-$16.0M-295%
Net income-$10.9M-255%
EPS (diluted)-$0.07-240%

Balance sheet

See full
Total debt$17.6M-5.7%
Total equity$242.9M+19.8%
Total assets$308.7M+14.1%

Cash flow

See full
Operating cash flow$1.9M-64.5%
CapEx$570.0K+51.2%
Free cash flow$1.3M-73.4%

Valuation

See full
Market cap$567.48M-33.9%
Enterprise value$425.3M-44.8%
P/E18.5×-2.9×
P/S1.5×-1.0×

Profitability

See full
Gross margin81%-0.9pp
Operating margin10.2%-5.1pp
Net margin7.9%-3.5pp
FCF margin17.8%-0.5pp

Returns & leverage

See full
Return on equity13.8%-8.6pp
Debt / equity0.1×0.0×
Current ratio5.4×+0.7×

Where this comes from

Reported directly by MiMedx Group in its filing.

Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents.

The official record: MiMedx Group’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →

Ask your AI about MiMedx Group's cash & equivalents.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is MiMedx Group's cash & equivalents?
MiMedx Group (MDXG) reported cash & equivalents of $159.77M in Q1 2026.
How has MiMedx Group's cash & equivalents changed year-over-year?
MiMedx Group's cash & equivalents increased by 50.1% year-over-year, from $106.43M to $159.77M.
What is the long-term trend for MiMedx Group's cash & equivalents?
Over 5 years (2020 to 2025), MiMedx Group's cash & equivalents has grown at a 11.6% compound annual growth rate (CAGR), from $95.81M to $166.12M.
What does cash & equivalents mean?
Cash on hand plus highly liquid investments with maturities of three months or less at purchase — treasury bills, money market funds, and commercial paper.